IN2013MU02953A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02953A
IN2013MU02953A IN2953MU2013A IN2013MU02953A IN 2013MU02953 A IN2013MU02953 A IN 2013MU02953A IN 2953MU2013 A IN2953MU2013 A IN 2953MU2013A IN 2013MU02953 A IN2013MU02953 A IN 2013MU02953A
Authority
IN
India
Prior art keywords
present
surface modified
therapeutic activity
targeted delivery
improved therapeutic
Prior art date
Application number
Inventor
Kamalinder Kaur Singh
Yogeeta Yeshwant Rajam
Sampada Shrikant Sawant
Aditi Abhay Sidhaye
Original Assignee
Kamalinder Kaur Singh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamalinder Kaur Singh filed Critical Kamalinder Kaur Singh
Priority to IN2953MU2013 priority Critical patent/IN2013MU02953A/en
Publication of IN2013MU02953A publication Critical patent/IN2013MU02953A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention discloses surface modified nanoparticles for targeted delivery of Antimalarial drug specifically to parasitized RBCs with improved therapeutic activity.
IN2953MU2013 2013-09-12 2013-09-12 IN2013MU02953A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2953MU2013 IN2013MU02953A (en) 2013-09-12 2013-09-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2953MU2013 IN2013MU02953A (en) 2013-09-12 2013-09-12

Publications (1)

Publication Number Publication Date
IN2013MU02953A true IN2013MU02953A (en) 2015-07-10

Family

ID=54396206

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2953MU2013 IN2013MU02953A (en) 2013-09-12 2013-09-12

Country Status (1)

Country Link
IN (1) IN2013MU02953A (en)

Similar Documents

Publication Publication Date Title
MX2020014300A (en) Heterocyclic compounds useful in the treatment of disease.
IL264901B (en) Administration of kynurenine depleting enzymes for tumor therapy
HK1216105A1 (en) Delivery of therapeutic agent
HK1221646A1 (en) Use of high dose pridopidine for treating huntingtons disease
MX350589B (en) Functional pla-peg copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging.
EP3004083A4 (en) Compounds for treatment of drug resistant and persistent tuberculosis
HK1215017A1 (en) Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases
EP3150202A4 (en) Drug carrier for tumour-specific targeted drug delivery and use thereof
PL2968218T3 (en) Combination for the treatment of parkinson's disease
EP2872120A4 (en) Targeted therapeutic nanoparticles
EP4005604C0 (en) Delivery of drugs
AU2016297823B2 (en) Methods for better delivery of active agents to tumors
EP2671586A4 (en) Drug therapy for preventing or treating glaucoma
EP2968881B8 (en) Apparatus for delivery of medication to the brain to treat neurological conditions
HK1220625A1 (en) Method of enhancing delivery of therapeutic compounds to the eye
EP2819741A4 (en) Solid drug implants for intracochlear delivery of therapeutics for the treatment of otic disorders
IN2013MU03918A (en)
EP2999461A4 (en) Targeted delivery of drugs to the myometrium
AU2014271207A1 (en) Targeted delivery of drugs to the myometrium
HK1256875A1 (en) Enhanced delivery of drugs to the brain
MX2020009966A (en) Dosage forms and therapeutic uses l-4-chlorokynurenine.
EP3003489A4 (en) Cytotoxic agents for the treatment of cancer
SG11201507254VA (en) Novel dosing regimens of celgosivir for the treatment of dengue
EP2895504A4 (en) Trpv3 agonists for the treatment of skin conditions
EP3094347A4 (en) Methods for enhancing the delivery of active agents